Navigation Links
China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
Date:8/19/2007

-- Revenues increase 28% to $8.9 Million for Q2 of 2007 versus $7 Million

for Q2 of 2006 -- Gross profit increases 18% to $2.2 Million for Q2 of 2007 versus $1.9

Million for Q2 of 2006 -- Announces LOI to Restructure $11.5 Million of Debt to Equity and Acquire

Remaining 49% of Erye

BEIJING, Aug. 15 /Xinhua-PRNewswire-FirstCall/ -- China Biopharmaceuticals Holdings, Inc. (OTC Bulletin Board: CHBP), a leading Chinese pharmaceutical company focused on the development, manufacturing and marketing of innovative drugs in China, today announced its results for the second quarter ended June 30, 2007.

Revenue for the three months ended June 30, 2007 increased 28% to $8.9 million compared to $7 million for the period ended June 30, 2006. The increase in revenues was mainly attributable to the 31% revenue growth of the Company's subsidiary Erye Pharmaceutical Limited Company ("Erye"). Additionally, the Company realized a full quarter of revenue this year from Enshi as opposed to last year when the acquisition of Enshi was made.

Recent industry developments in China have provided Erye a great opportunity to continue to grow its core business going forward. The Chinese government has invested billions of dollars in a new insurance policy called "Cooperative Medicare." This policy is aimed at providing insurance for farmers in China. Erye will provide their products, which are currently focused on middle-end to low-end markets, to these farmers under the new policy.

Cost of goods sold increased 31% to $6.7 million for the second quarter of 2007 compared to $5.1 million for the second quarter of 2006. Cost of goods sold as a percentage of sales revenues was approximately 75% for the three months ended June 30, 2007 compared to 74% for the three months ended June 30, 2006. The increase in cost of goods sold has remained consistent with the growth of sales for th
'/>"/>

SOURCE China Biopharmaceuticals Holdings, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. How do you level the playing field with China?
2. Speaker announces business members of IT Task Force
3. Doyle announces technology tax credits for Berbee
4. Doyle announces new energy, global warming policies
5. Doyle announces $80M renewable energy strategy
6. GE announces first installation of Discovery VCT
7. UWM announces winners of RGI awards
8. Third Wave announces two senior management appointments
9. Mirus announces new method for making antibodies
10. Merge announces sofware updates, upcoming acquisition
11. Small Tree announces ethernet solution for Apple Xserv G5

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)..., , BLAUVELT, N.Y., Nov. 19 ...at germ extract, responds to a press release issue...he Hungarian company for making false and self-ser... BioSciences. ,, Dr. Hidvegi stated from his o... claim that research on Avemar does not apply to A...
(Date:11/19/2009)..., , MUNSTER, Germany, November 19 /PR...they have filed on November 16th, 2009 Flibanserin...uced dyskinesia in Parkinson,s,disease for orphan ...s Agency,(EMEA). Levodopa-induced dyskinesia is a ... Parkinson,s and a serious burden to some of those...
(Date:11/19/2009)..., , VIENNA, Austria, November 19 /PR... vaccine program on one product candidate at an un... candidate AD02 is planned to enter into,Phase II ... company,immediately follows the completion of two... The company based its fast decision on the first ...
(Date:11/18/2009)... Scientists at Queen,s University Belfast are deve...llegal drugs which will help in the fight against ...ill use special gel pads to ,swipe, an individual ...alysed by a scanning instrument that can detect th...allow better, faster decisions to be made in respo...
Breaking Biology Technology:American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3New technology detects chemical weapons in seconds 2
... I didnt realize the depth of the task in front of... Midwest list of public and private biotech compan..., lets first start with Illinois, which is the cen...imated that there were between 200 and 300 biotech... these being public companies. My guesstimate at t...
...- U.S. Representative Tammy Baldwin and Wisconsin ...nsin companies will each receive federal grants of... and product development efforts. , ,Both based in...StrataGraft" skin tissue that could serve as synth...nologies that use non-flammable, renewable feed st...
...li Lilly & Company recently expressed concern to D...hat the HIPAA privacy rule may impede clinical res...acklogged with requests to review and approve thou...sure of information, according to a letter from St...based Eli Lilly. , ,In a response letter, Richard...
Other Biology Technology:ePrairie Uncovers 80 Biotech Companies in Illinois 2ePrairie Uncovers 80 Biotech Companies in Illinois 3ePrairie Uncovers 80 Biotech Companies in Illinois 4ePrairie Uncovers 80 Biotech Companies in Illinois 5ePrairie Uncovers 80 Biotech Companies in Illinois 6ePrairie Uncovers 80 Biotech Companies in Illinois 7ePrairie Uncovers 80 Biotech Companies in Illinois 8ePrairie Uncovers 80 Biotech Companies in Illinois 9ePrairie Uncovers 80 Biotech Companies in Illinois 10ePrairie Uncovers 80 Biotech Companies in Illinois 11ePrairie Uncovers 80 Biotech Companies in Illinois 12ePrairie Uncovers 80 Biotech Companies in Illinois 13ePrairie Uncovers 80 Biotech Companies in Illinois 14ePrairie Uncovers 80 Biotech Companies in Illinois 15ePrairie Uncovers 80 Biotech Companies in Illinois 16ePrairie Uncovers 80 Biotech Companies in Illinois 17Stratatech and Virent Win $4M in U.S. Grants 2Stratatech and Virent Win $4M in U.S. Grants 3Stratatech and Virent Win $4M in U.S. Grants 4Stratatech and Virent Win $4M in U.S. Grants 5
(Date:11/20/2009)...al molecules like RNA and DNA is how they first ca...ursors. Now, in a study appearing in this week,s J... the earliest evolutionary steps yet: generating l...othing but warm water. , Many researchers belie...les present, before DNA and proteins; however, the...
(Date:11/20/2009)...ess an ingenious mechanism for preventing oxygen f...is the new finding of a team of biologists that in...rch institute in Flanders, Belgium, connected to t... this discovery by modifying the DNA of the intest...s model organism, they have uncovered the existenc...
(Date:11/20/2009)...(ERC) has been awarded a grant from the U.S. Depar...ring and reusing the heat that would be generated ...in a carbon capture system. The goal of the resear...uestration, or storage (CCS), and thus limit the a... atmosphere by coal-fired power plants. , Unlike...
Breaking Biology News(10 mins):Biologists discover bacterial defense mechanism against aggressive oxygen 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 3Orlando Regional Medical Center 28ORMC 29 Implements PNA FISH 28R 29 Tests to Help Provide Better Care for Patients with Bloodstream Infections 52229 1Orlando Regional Medical Center 28ORMC 29 Implements PNA FISH 28R 29 Tests to Help Provide Better Care for Patients with Bloodstream Infections 52229 2Orlando Regional Medical Center 28ORMC 29 Implements PNA FISH 28R 29 Tests to Help Provide Better Care for Patients with Bloodstream Infections 52229 3Kashi Company Introduces TLC 28R 29 Dark Mocha Almond Chewy Bar 52224 1Kashi Company Introduces TLC 28R 29 Dark Mocha Almond Chewy Bar 52224 2Novasys Medical Receives 2418 95 Million in Second Tranche of Series D Financing 52219 1Novasys Medical Receives 2418 95 Million in Second Tranche of Series D Financing 52219 2
...e long, thin molecule that carries our hereditary ... in the cell nucleus into tiny spheres called nucl...g the entire chromosome, which is itself folded an...s how, when and where a nucleosome will be positio...earch student Yair Field of the Computer Science a...
...y years, researchers believed that stem cells in t...slumber-like state, unaware of -- and unaffected b... system. , Not so. , Scientists at the Oklahoma M...rrow stem cells -- undifferentiated cells that eve...fection -- possess receptors that recognize bacter...
...in,s septum helps prevent epileptic seizures by in...its of another area of the brain known as the hipp...f Neurophysiology. The researchers found that, by ...ileptic rats, they could reduce epileptic seizures...networks in chronically epileptic rats: Potential ...
Other Biology News:Scientists discover a genetic code for organizing DNA within the nucleus 2Scientists discover a genetic code for organizing DNA within the nucleus 3Can you hear me now? Scientists find previously unknown receptors on adult stem cells 2Septum keeps neurons in synch, can reduce epileptic seizures by 90 percent 2Septum keeps neurons in synch, can reduce epileptic seizures by 90 percent 3
...statistical interpretation to researchers, product...an accepted organizational standard for analytics ...users and includes the comprehensive analytics nee... Language (JSL), a menu generator, and journaling ...
Mouse Anti-Yersinia pestis F1 antigen Monoclonal Antibody, Unconjugated, Clone YPF19 from Novus Biologicals
RNAsin from BD Biosciences Pharmingen
Newborn Calf Serum, Heat Inactivated from Sigma-Aldrich
Biology Products: